Abstract

British Society of Gastroenterology Guidance for Management of Inflammatory Bowel Disease During the COVID-19 Pandemic

Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244.Epub 2020 Apr 17.

Nicholas A Kennedy 1 2, Gareth-Rhys Jones 3 4, Christopher A Lamb 5 6, Richard Appleby 7, Ian Arnott 4, R Mark Beattie 8, Stuart Bloom 9, Alenka J Brooks 10, Rachel Cooney 11 12, Robin J Dart 13 14, Cathryn Edwards 15, Aileen Fraser 16, Daniel R Gaya 17 18, Subrata Ghosh 11 12, Kay Greveson 14, Richard Hansen 18 19, Ailsa Hart 20 21, A Barney Hawthorne 22, Bu'Hussain Hayee 13 23, Jimmy K Limdi 24 25, Charles D Murray 14, Gareth C Parkes 26 27, Miles Parkes 28, Kamal Patel 29, Richard C Pollok 29 30, Nick Powell 21 31, Chris S Probert 32 33, Tim Raine 28, Shaji Sebastian 34, Christian Selinger 35, Philip J Smith 32, Catherine Stansfield 36, Lisa Younge 37, James O Lindsay 26 27, Peter M Irving 13 38, Charlie W Lees 39 4

 
     

Author information

1Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

2University of Exeter, Exeter, UK.

3University of Edinburgh, Edinburgh, UK.

4Western General Hospital, Edinburgh, UK.

5Newcastle University, Newcastle upon Tyne, UK.

6Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

7Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

8Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

9University College London Hospitals NHS Foundation Trust, London, UK.

10Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

11Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

12University of Birmingham, Birmingham, UK.

13King's College London, London, UK.

14The Royal Free Hospital, London, UK.

15Torbay and South Devon NHS Foundation Trust, Torquay, UK.

16University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

17Glasgow Royal Infirmary, Glasgow, UK.

18University of Glasgow, Glasgow, UK.

19Royal Hospital for Children, Glasgow, UK.

20St Mark's Hospital, London, UK.

21Imperial College London, London, UK.

22University Hospital of Wales, Cardiff, UK.

23King's College Hospital NHS Foundation Trust, London, UK.

24The Pennine Acute Hospitals NHS Trust, Manchester, UK.

25University of Manchester, Manchester, UK.

26Barts and the London School of Medicine and Dentistry, London, UK.

27The Royal London Hospital, Barts Health NHS Trust, London, UK.

28Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

29St George's University Hospitals NHS Foundation Trust, London, UK.

30St George's, University of London, London, UK.

31Imperial College Healthcare NHS Trust, London, UK.

32Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK.

33University of Liverpool, Liverpool, UK.

34Hull University Teaching Hospitals NHS Trust, Hull, UK.

35Leeds Teaching Hospitals NHS Trust, Leeds, UK.

36Salford Royal NHS Foundation Trust, Salford, UK.

37Crohn's and Colitis UK, St Albans, Hertfordshire, UK.

38Guy's and St Thomas' NHS Foundation Trust, London, UK.

39University of Edinburgh, Edinburgh, UK charlie.lees@ed.ac.uk.

Abstract

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.